Table 3.
IOP and IOP-Lowering Medication Outcomes at Baseline and Each Post-Implant Time Point in the Total Population and Subgroups Differentiated by Baseline IOP of 21 mmHg
| Parameter | Baseline | Month 1 | Month 6 | Month 12 |
|---|---|---|---|---|
| Eyes with decrease in IOP ≥20%, n (%) | ||||
| Total population | NA | 44 (28.21) | 47 (30.13) | 64 (41.03) |
| IOP≥21 | NA | 28 (52.83) | 30 (56.60) | 39 (73.58) |
| IOP<21 | NA | 16 (15.53) | 17 (16.50) | 25 (24.27) |
| Medication-free, n (%) | ||||
| Total population | 33 (21.15) | 114 (73.08) | 97 (62.18) | 67 (42.95) |
| IOP≥21 | 21 (39.62) | 36 (67.92) | 30 (56.60) | 22 (41.51) |
| IOP<21 | 12 (11.65) | 78 (75.73) | 67 (65.05) | 45 (43.69) |
| Reduction in medications ≥1, n (%) | ||||
| Total population | NA | 100 (64.10) | 92 (58.97) | 81 (51.92) |
| IOP≥21 | NA | 20 (37.74) | 17 (32.08) | 16 (30.19) |
| IOP<21 | NA | 80 (77.67) | 75 (72.82) | 65 (63.11) |
| Same or lower number of medications | ||||
| Total population | NA | 153 (98.1%) | 144 (92.3%) | 127 (81.4%) |
| IOP≥21 | NA | 51 (96.2%) | 46 (86.8%) | 36 (67.9%) |
| IOP<21 | NA | 102 (99%) | 88 (85.4%) | 91 (88.3%) |
Abbreviations: IOP, intraocular pressure; NA, not applicable.